Document is current

Article History

Received: 24 July 2024

Accepted: 1 October 2024

First Online: 18 October 2024

Declarations

:

: Xabier Michelena has received speaking fees and honoraria as advisor from: Abbvie, Janssen, Lilly, Novartis and UCB. Clementina López Medina has received honoraria as speaker fees/consulting from: Abbvie, Janssen, Lilly, MSD, Novartis, Pfizer and UCB. Eugenio De Miguel has received research funding/consulting and conferences fees from: Abbvie, Novartis, Roche, Pfizer, Janssen, Lilly, MSD, BMS, UCB, Grunental and Sanofi. Manuel José Moreno Ramos has received unrelated honoraria or research grants from Abbvie, Amgen, Janssen, Lilly, MSD, Novartis, Pfizer and UCB, and advisor´s honoraria from Abbvie, Janssen, Lilly, Novartis, Pfizer and UCB unrelated to the present work. Rubén Queiro has received honoraria as a panellist, consultant, speaker and researcher from: Abbvie, Celgene-Amgen, Janssen, Lilly, MSD, Novartis, Pfizer, and UCB. Helena Marzo-Ortega has received grant support from Janssen, Novartis, Pfizer and UCB. Honoraria and/or speaker fees from AbbVie, Amgen, Biogen, Eli-Lilly, Janssen, Moonlake, Novartis, Pfizer, Takeda and UCB. Xavier Juanola has received honoraria as a panellist, consultant, speaker or researcher from Abbvie, Lilly, MSD, Novartis, Pfizer and UCB.

: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.